Folate and vitamin B12
- 1 May 1999
- journal article
- review article
- Published by Cambridge University Press (CUP) in Proceedings of the Nutrition Society
- Vol. 58 (2) , 441-448
- https://doi.org/10.1017/s0029665199000580
Abstract
The folates are made up of a pterdine ring attached to a p-aminobenzoate and a polyglutamyl chain. The active form is tetrahydrofolate which can have C1 units enzymically attached. These C1 units (as a formyl group) are passed on to enzymes in the purine pathway that insert the C−2 and C−8 into the purine ring. A methylene group (−CH2−) attached to tetrahydrofolate is used to convert the uracil-type pyrimidine base found in RNA into the thymine base found in DNA. A further folate cofactor, i.e. 5-methyltetrahydrofolate, is involved in the remethylation of the homocysteine produced in the methylation cycle back to methionine. After activation to S-adenosylmethionine this acts as a methyl donor for the dozens of different methyltransferases present in all cells. Folate deficiency results in reduction of purine and pyrimidine biosynthesis and consequently DNA biosynthesis and cell division. This process is most easily seen in a reduction of erythrocytes causing anaemia. Reduction in the methylation cycle has multiple effects less easy to identify. One such effect is certainly on the nerve cells, because interruption of the methylation cycle causing neuropathy can also happen in vitamin B12 deficiency due to reduced activity of the vitamin B12-dependent enzyme methionine synthase (EC 2.1.1.13). In vitamin B12 deficiency, blocking of the methylation cycle causes the folate cofactors in the cell to become trapped as 5-methyltetrahydrofolate. This process in turn produces a pseudo folate deficiency in such cells, preventing cell division and giving rise to an anaemia identical to that seen in folate deficiency.Keywords
This publication has 16 references indexed in Scilit:
- Homocysteine and Ischemic Heart DiseaseArchives of internal medicine (1960), 1998
- Thermolabile variant of 5, 10-methylenetetrahydrofolate reductaseassociated with low red-cell folates: implications for folate intake recommendationsThe Lancet, 1997
- Homocysteine and cardiovascular diseaseQJM: An International Journal of Medicine, 1996
- Folate Levels and Neural Tube DefectsJAMA, 1995
- Folate levels and neural tube defects. Implications for preventionJAMA, 1995
- The role of folate in the prevention of neural-tube defectsProceedings of the Nutrition Society, 1994
- Accelerated folate breakdown in pregnancyThe Lancet, 1993
- Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrationsAmerican Journal of Hematology, 1990
- PATHOGENESIS OF SUBACUTE COMBINED DEGENERATION: A RESULT OF METHYL GROUP DEFICIENCYThe Lancet, 1981
- Folate-responsive neuropathy: report of 10 cases.BMJ, 1976